Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Patients”

9,925 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 9,925 results

Post-approval studies (Phase 4)Study completedNCT02669082
What this trial is testing

The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy

Who this might be right for
InsomniaMajor Depressive Disorder
Takeda 26
Post-approval studies (Phase 4)Active Not RecruitingNCT04619082
What this trial is testing

TAF to Prevent HBV Reactivation in Cancer Patients

Who this might be right for
Hepatitis B Reactivation
Chiayi Christian Hospital 102
Large-scale testing (Phase 3)Study completedNCT00003159
What this trial is testing

Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Medical Research Council 600
Testing effectiveness (Phase 2)WithdrawnNCT01933061
What this trial is testing

Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Celgene Corporation
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00559156
What this trial is testing

Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Head and Neck Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 46
Testing effectiveness (Phase 2)Study completedNCT02448329
What this trial is testing

Study of AZD1775 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring TP53 Mutation as a Second-line Chemotherapy

Who this might be right for
Advanced Gastric Adenocarcinoma
Samsung Medical Center 26
Testing effectiveness (Phase 2)Study completedNCT01619423
What this trial is testing

A Trial of PledOx + FOLFOX6 Compared to Placebo + FOLFOX6 in Patients With Metastatic Colorectal Cancer

Who this might be right for
Advanced Metastatic (Stage IV) Colorectal Cancer
Egetis Therapeutics 186
Testing effectiveness (Phase 2)Ended earlyNCT00005986
What this trial is testing

Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Masonic Cancer Center, University of Minnesota
Not applicableUnknownNCT00354705
What this trial is testing

Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients

Who this might be right for
Colon Cancer
M.D. Anderson Cancer Center 200
Testing effectiveness (Phase 2)Study completedNCT00470054
What this trial is testing

Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 44
Not applicableStudy completedNCT00512551
What this trial is testing

DNA Array Analysis of Patients With Cervical Cancer

Who this might be right for
Cervical Cancer
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Ended earlyNCT01986829
What this trial is testing

Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy

Who this might be right for
OsteosarcomaSarcoma
Washington University School of Medicine 9
Early research (Phase 1)Study completedNCT01238562
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients

Who this might be right for
Chemotherapy Patients
Xiamen Amoytop Biotech Co., Ltd. 30
Not applicableActive Not RecruitingNCT05181488
What this trial is testing

Intraoperative Radiation Therapy for Resectable Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
Yona Cho 80
Testing effectiveness (Phase 2)Looking for participantsNCT04105270
What this trial is testing

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Who this might be right for
Adenocarcinoma of LungLung Cancer
Masonic Cancer Center, University of Minnesota 82
Not applicableLooking for participantsNCT05317494
What this trial is testing

Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece

Who this might be right for
Acute Myeloid Leukemia
AbbVie 100
Large-scale testing (Phase 3)Looking for participantsNCT04597294
What this trial is testing

Prophylactic Preoperative HIPEC in Advanced Gastric Cancer at High Risk of Peritoneal Recurrence

Who this might be right for
Gastric Cancer
Jagiellonian University 600
Early research (Phase 1)WithdrawnNCT01296659
What this trial is testing

Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
The University of Texas Health Science Center at San Antonio
Not applicableLooking for participantsNCT06473259
What this trial is testing

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerHormone Sensitive Prostate CancerMetastatic Tumor
Santa Chiara Hospital 3,000
Load More Results